As filed with the Securities and Exchange Commission on May 20, 2024. Registration No. 333-279324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NeuroSense Therapeutics Ltd. (Exact Name of Registrant as Specified in Its Charter) Not Applicable (Translation of Registrant's name into English) State of Israel 2834 Not Applicable (State or Other Jurisdiction of Incorporation or Organization) (Primary Standa ...